Brokerages Set Milestone Pharmaceuticals Inc. (NASDAQ:MIST) PT at $17.00
Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) have earned a consensus recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price […]
Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) have earned a consensus recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price […]
